Q over Q script numbers are going to be great, Revenue Y over Y and Q over Q are going to be great.
Well you would have to start with the fact that your 30% responder rate is not accurate. Responder rate in the study was almost 50% and in the real world they are seeing much higher numbers...
The DEA is to blame for the first 11 month delay... no reason for that what so ever... Since launch we have done well the first year on the market..
I am actually very pleased when you consider we only had 4 day. The week before was 11,101 / 5 days that is 2,220 scripts a day, so a fair guess would be that we would see this drop by almost that much. But we dropped 1,000 less then that.
It is funny how A Fartstain came out with the numbers so quickly....
They guys is cherry picking on data set out of context...
Does he take into consideration that expenses went up 50% due to pipeline activity and increases in SG & A? Nope
Does he look at Q over Q or Y over Y revenue growth? Nope
Does he look at the percentage increase in scripts Q over Q, scripting doctors Q over Q? Nope
He is cherry picking a single bad number. So answer his question and then use your brain to explain why the numbers is there and how it will change soon.
I think you need to go back and look at my posting history before you attack. I simply answered his question with facts. "Deceiving little pea brain" what about any of my post is not true or "deceiving" ?
But those numbers don't tell the whole story and he knows it.
I have been long this stock since long before the first PDUFA
Change in cash was (18,606) so if we did nothing else but stay there and did not grow revenue we would burn less then 76 million for the year. This should be the last year we burn significant amounts of cash, bumping up our expenses 40 million plus a year was not what I wanted but it is what it is.
First, welcome to the board. What brought you here?
Second, we have a very large percentage of bashers and id's clones here. So do some DD on the posters here and take note to their true spelling. It will take you a while to determine who is real and who is not. Good luck with that.
Long term investor in Arena since a year before the first PDUFA and adding to that position for years.
short is underwater and you keep thinking it will pull back and small losses turn into major losses..
- calling for a new Anti disruptive trading rules to be worked out by the SEC commission
- Eliminate FINRA exemptions for dealers and off exchange venues
- Look into and inside Algos
- Low latency tools need to be reviewed direct vs. consolidated feeds
will open their books and make their moves more transparent. I like it a game changer... Lets hope they actually put real rules in place and really curb the secret behavior.
Belviq has been growing scripts by more then Q for 20 weeks in a row and today we are scripting more in real numbers and actual reported numbers... But you already know this that is why you posted an outright lie.
They committed to running the TV ads through out the year and are bringing on 200 more sales reps. The CEO of Eisai is coming to America on July 7 for the "RE LAUNCH". They continue to file in other countries for Belviq approval and are moving forward with their studies for a re submission in the EU by the end of the year.
These are not the actions of someone that is giving up on a drug.
Not for a while. 3.5 months ago we had 20,000 doctors that had scripted the drug a couple days ago that number is 33,500. It is going to take time for those new doctors to see the results from their patients and to get a handle on the responder percentage and the side effects reported. Once they have a few success then they will start to script a lot more. I figure by the end of third quarter we will be close to 50,000 doctors and half of those should have enough history with the drug to start using it as their first line of treatment for obesity. So the third quarter is when I think we will start to see the script take off.